Data suggest photodynamic therapy with the investigational topical methyl aminolevulinate may be an effective treatment for patients with severe facial acne.
News
All News
Mindfulness can be integrated in dermatology management and has been demonstrated in research to improve clearance of conditions for patients and to improve anxiety and depression that patients experience associated with their skin conditions.
The Summer 2016 Meeting of the American Academy of Dermatology kicks off Thursday, July 28, in Boston.
Cheryl Bisera explains the importance of using video in marketing material for your medical practice and also provides tips to make videos effective and powerful.
Results from three phase 3 trials, suggest ixekizumab (Talz, Eli Lilly & Company) is effective through 60 weeks of treatment among patients with moderate-to-severe plaque psoriasis.
The acne app offers a free and immediate analysis of acne type and severity; develops an individualized acne control plan; and monitors users’ progress. It aims to help consumers diagnose, treat, manage and prevent acne.
Mohs surgery experts advise when Mohs is and isn’t optimal skin cancer treatment.
UK-based Ziarco Pharma Ltd. recently announced positive phase 2a results for ZPL-389, a once daily oral histamine H4 receptor antagonist, for the treatment of moderate to severe atopic dermatitis.
The systemic therapy dupilumab met primary endpoints in two phase 3 studies on adults with in inadequately controlled moderate-to-severe atopic dermatitis.
Scientists are digging into the past in search of genetic insight into modern skin diseases. Here are some of the hottest topics in the study of human history and skin disease.
How does the standard of care relate to medical coding?
Recent actions around drug compounding, sunscreen ingredient approvals, drugs and medical devices, cosmetic product marketing and more will affect your practice. Stay informed.
Optimal wound healing practices have changed in recent years. some techniques are no longer best practice and new techniques have emerged.
Researchers at the University of Würzburg in Bavaria, Germany, are focusing their psoriasis research on a cell type that has received little attention in connection with the skin disease: B lymphocytes.
The trend toward smaller biopsies may compromise the accuracy of dermatopathologists' diagnoses.
Hair loss after hair dyeing is common due to the manipulation of the hair shafts during the dyeing procedure.
Many dietary supplements have entered the market to support increased hair growth
It appears that patients with long hair are more often concerned about hair loss.
A new study suggests that insurance coverage of biologics for psoriasis is becoming more challenging. The need for prior authorization is increasing, as are the average time from prior authorization submission to coverage decisions and prior authorization denial rates.
Looks like marketing and publicity might have outpaced the validity and usefulness of a test used to detect Lyme disease.
Key resources for patients, families and healthcare providers who deal with alopecia areata include the National Alopecia Areata Foundation, the Children's Alopecia Project and the American Academy of Dermatology.
American Ninja Warrior competitor Kevin Bull is helping to boost awareness about alopecia areata, while researchers are beginning to tap the potential of JAK inhibitors for this indication.
Blogging is a very well respected and effective form of marketing that resonates with today’s internet-savvy, relationship-based consumers (i.e. patients). Here's why you should be blogging and how to get started.
The role of dermoscopy has expanded beyond melanoma detection. Experts offer best practices and explain how to embrace and use this powerful tool to get more complete and accurate diagnoses.
We asked you what your key challenges have been this year. These are your top-of-mind concerns.
There can often be delays in identifying SCARs and related conditions like TEN and SJS. The optimal management of these presentations involves multidisciplinary care.
MIPS will replace the Physician Quality Reporting System (PQRS) and CMS will adjust Medicare payments to most physicians either up or down by as much as 9% depending on how well they score in four performance categories. One expert shares insight based on a recent article published in JAMA Forum.
Researchers have uncovered new pathways that control skin lightening and tanning, which could lead to a novel class of therapeutics for treating pigmentation disorders.
Some unconventional therapies for rosacea get to the root of the problem, with apparent positive impacts on inflammation, skin barrier dysfunction and vascular function.
A seasoned dermatologist shares his views about dermatologists being overpaid, when to treat and when not to treat, and how best to stay informed.